Yabao Pharmaceutical Group Co., Ltd (600351.SS)
CNY 6.27
(-0.16%)
CNY 6.27
(-0.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 497.55 Million | 460.46 Million | 437.5 Million | 380.96 Million | 425.16 Million | 426.6 Million |
| Net Income | 179.91 Million | 104.6 Million | 183.76 Million | 108.98 Million | 10.79 Million | 284.01 Million |
| Depreciation & Amortization | 159.2 Million | 163.82 Million | 171.05 Million | 169.88 Million | 172.68 Million | 171.41 Million |
| Deferred income taxes | 4.1 Million | -7.52 Million | -8.33 Million | -656.24 Thousand | -5.22 Million | -3.54 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 48.44 Million | 91.45 Million | 52.07 Million | 63.25 Million | -108.06 Million | -81.69 Million |
| Other non-cash items | 13.37 Million | 100.57 Million | 30.6 Million | 38.83 Million | 349.75 Million | 52.86 Million |
| Investing Cash Flow | -127.37 Million | -96.73 Million | -125.37 Million | -209.52 Million | -163.47 Million | -79.59 Million |
| Investments in PPE | -99.85 Million | -62.23 Million | -95.05 Million | -62.86 Million | -157.09 Million | -68 Million |
| Acquisitions | 14.58 Million | 1.25 Million | 1.13 Million | -8.05 Million | 175.64 Million | - |
| Investment purchases | -103.52 Million | -165.54 Million | -162.56 Million | -272.06 Million | -1.82 Billion | -2.81 Billion |
| Sales/Maturities of investments | 61.42 Million | 129.78 Million | 131.1 Million | 129.23 Million | 1.8 Billion | 2.79 Billion |
| Other Investing Activities | -27.51 Million | 0.77 | 0.48 | 4.22 Million | -157.09 Million | 1.17 Million |
| Financing Cash Flow | -446.75 Million | -178.63 Million | -186.62 Million | -314.78 Million | -472.96 Million | -57.41 Million |
| Debt repayment | -240.8 Million | -712.6 Million | -643.28 Million | -1.11 Billion | -1.36 Billion | -857.17 Million |
| Dividends payments | -38.4 Million | -61.6 Million | -38.5 Million | -15.4 Million | -192.5 Million | -113.15 Million |
| Common Stock Repurchased | -150.44 Million | - | - | - | -5.95 Million | -107.08 Million |
| Common Stock Issuance | - | - | - | - | 5.95 Million | - |
| Other Financing Activities | -154.68 Million | 615.57 Million | 517.06 Million | 844.88 Million | 1.12 Billion | 912.91 Million |
| Accounts receivables | 69.27 Million | -6.95 Million | 49.91 Million | 137.79 Million | -24.15 Million | -232.43 Million |
| Accounts payables | -22.41 Million | 44.9 Million | 42.9 Million | -134.11 Million | -56.24 Million | 204.68 Million |
| Inventory | -2.51 Million | 61.02 Million | -32.4 Million | 60.23 Million | -22.44 Million | -50.4 Million |
| Other working capital | -18.31 Million | -7.52 Million | -8.33 Million | -656.24 Thousand | -5.22 Million | -31.29 Million |
| Cash at beginning of period | 642.02 Million | 456.7 Million | 331.24 Million | 474.45 Million | 685.73 Million | 396.01 Million |
| Cash at end of period | 565.46 Million | 642.02 Million | 456.7 Million | 331.24 Million | 474.45 Million | 685.73 Million |
| Capital Expenditure | -99.85 Million | -62.23 Million | -95.05 Million | -62.86 Million | -157.09 Million | -68 Million |
| Effect of forex changes on cash | 12.83 Thousand | 222.38 Thousand | -51.18 Thousand | 138.43 Thousand | -6826.06 | 128.71 Thousand |
| Net cash flow / Change in cash | -76.55 Million | 185.31 Million | 125.45 Million | -143.2 Million | -211.28 Million | 289.71 Million |
| Free Cash Flow | 397.69 Million | 398.23 Million | 342.45 Million | 318.09 Million | 268.07 Million | 358.59 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 55.15 Million | 67.51 Million | 112.26 Million | 179.91 Million | -14.23 Million | 45.78 Million |
| Depreciation & Amortization | - | 35.6 Million | 35.6 Million | 159.2 Million | 39.84 Million | -79.55 Million |
| Deferred income taxes | - | - | - | 4.1 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 50.62 Million | - | 48.44 Million | 66.75 Million | -67.02 Million |
| Other non-cash items | -14.83 Million | 30.78 Million | 168.28 Million | 13.37 Million | 217.41 Million | 180.58 Million |
| Investing Cash Flow | -14.06 Million | -15.64 Million | -10.19 Million | -127.37 Million | -219.45 Thousand | -72.15 Million |
| Investments in PPE | -12.56 Million | -5.6 Million | -10.14 Million | -99.85 Million | -19.79 Million | -30.74 Million |
| Acquisitions | 739.92 Thousand | 7660.00 | 132.2 Thousand | 14.58 Million | 14.06 Million | 295.95 Thousand |
| Investment purchases | -2.28 Million | -14.16 Million | -926.29 Thousand | -103.52 Million | -34.57 Million | -47.44 Million |
| Sales/Maturities of investments | 45.17 Thousand | 4.12 Million | 743.93 Thousand | 61.42 Million | 40.08 Million | 5.73 Million |
| Other Investing Activities | 739.92 Thousand | -10.11 Million | 1.14 Million | -27.51 Million | 19.57 Million | 0.12 |
| Financing Cash Flow | -71.4 Million | -110.59 Million | -176.07 Million | -446.75 Million | -102.37 Million | -134.39 Million |
| Debt repayment | -112 Million | - | -90 Million | -240.8 Million | -49.6 Million | -319.8 Million |
| Dividends payments | -108 Million | -108 Million | -1.79 Million | -38.4 Million | -38.4 Million | -2.57 Million |
| Common Stock Repurchased | 171.67 Million | -171.67 Million | - | -150.44 Million | -150.44 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 42.28 Million | 172.98 Million | -176.07 Million | -154.68 Million | -50.65 Million | 187.98 Million |
| Accounts receivables | - | 21.43 Million | - | 69.27 Million | 69.27 Million | -10.55 Million |
| Accounts payables | - | - | - | -22.41 Million | - | - |
| Inventory | - | 29.19 Million | - | -2.51 Million | -2.51 Million | -56.46 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 596.25 Million | 665.68 Million | 583.43 Million | 642.02 Million | 505.01 Million | 631.79 Million |
| Cash at end of period | 551.05 Million | 599.58 Million | 665.68 Million | 565.46 Million | 565.46 Million | 505.01 Million |
| Capital Expenditure | -12.56 Million | -5.6 Million | -10.14 Million | -99.85 Million | -19.79 Million | -30.74 Million |
| Effect of forex changes on cash | -2544.72 | 18.2 Thousand | 31.48 Thousand | 12.83 Thousand | 24.44 Thousand | -25.98 Thousand |
| Net cash flow / Change in cash | -45.19 Million | -66.09 Million | 82.25 Million | -76.55 Million | 60.44 Million | -126.77 Million |
| Free Cash Flow | 27.75 Million | 57.08 Million | 270.4 Million | 397.69 Million | 143.54 Million | 49.05 Million |
GE
ALMS
GAMB
E3B
4374
1137